Alpha Profiles · Company Profile

SUPERNUS PHARMACEUTICALS, INC.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc

Entity: Public listing published
Primary listing: NASDAQ: SUPN
Verification: Partially verified
Last reviewed: 2026-10-05T15:31:21.915751+00:00

Overview

Alpha's canonical identity and public leadership record for SUPERNUS PHARMACEUTICALS, INC..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Frank Mottola

Senior Vice President, Chief Technical Operations Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

Jack A. Khattar

President, Chief Executive Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

Jonathan Rubin

Senior Vice President, Chief Medical Officer, Research and Development

State: confirmed
Effective: From Apr 30, 2026
Confidence: 94%
Evidence: SUPN DEF 14A executive officersApr 30, 2026

Jonathan Rubin, M.D.

Senior Vice President, Chief Medical Officer, Research and Development

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

Padmanabh P. Bhatt, Ph.D.

Senior Vice President of Intellectual Property, Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

Prat S. Bhatt

Senior Vice President of Intellectual Property, Chief Scientific Officer

State: confirmed
Effective: From Apr 30, 2026
Confidence: 94%
Evidence: SUPN DEF 14A executive officersApr 30, 2026

Timothy C. Dec

Senior Vice President, Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

William Todd Horich

Senior Vice President, Commercial Operations, Marketing, and Market Access

State: confirmed
Effective: From Apr 30, 2026
Confidence: 94%
Evidence: SUPN DEF 14A executive officersApr 30, 2026

William Todd Horich, Ph.D., MBA

Senior Vice President, Commercial Operations, Marketing, and Market Access

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053111Apr 30, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 5, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.